Mytilineos S.A. (MYTIL:ATH) EPS €
The best online stock broker. Open an account today and start earning up to $1000 of IBKR Stock !
Monday, January 31, 2022
Sunday, January 30, 2022
MYTILINEOS S.A. (MYTIL:ATH) REVENUE & NET INCOME€
MYTILINEOS S.A. (MYTIL:ATH) REVENUE & NET INCOME €
The shares of our page with the best and worst performance of the week
The shares of our page with the best and worst performance of the week
The financial and technical analycies presented on this website have not been performed by an Investment Services Company, nor have they been compiled by a certified analyst . It is simply a display and presentation of public data of Greek and foreign shares with informative and entertaining character.
Zepp Health (ZEPP:NASDAQ)
NASDAQ is in a downward spiral
VALUE INVESTING STORIES 7 - ANDRE COSTOLANY
10 years of rise for the share of Mytilineos 2012-2022
Saturday, January 29, 2022
Thursday, January 27, 2022
Mytilineos S.A. (MYTIL:ATH) REVENUE €
Mytilineos S.A. (MYTIL:ATH) REVENUE € UPDATE 
CLICK ON THE IMAGE
Wednesday, January 26, 2022
Tuesday, January 25, 2022
BAYER: Leaps by Bayer leads $80M Series A Financing for Cellino Biotech to Autonomize Stem Cell Therapy Manufacturing
Leaps by Bayer leads $80M Series A Financing for Cellino Biotech to Autonomize Stem Cell Therapy Manufacturing
Cellino aims to significantly expand patient access to stem cell-based therapies with autonomous end-to-end manufacturing / Proceeds will expand machine learning, software, and hardware capabilities and to develop early-stage Good Manufacturing Practice (GMP) capabilities to support clinical trials, with plans to build the first autonomous human cell foundry in 2025 / Investment further strengthens existing company portfolio of Leaps by Bayer in the fields of cell and gene therapies
Cambridge, MA, US and Leverkusen, Germany / January 25, 2022 – Cellino Biotech, Inc., an autonomous cell therapy manufacturing company, today announced the completion of a Series A financing of $80 million, led by the impact investment arm of Bayer AG – Leaps by Bayer – 8VC, and Humboldt Fund. New investors in the round include Felicis Ventures and others, joining existing investors The Engine and Khosla Ventures. The company has raised a total of $96 million i
Subscribe to:
Posts (Atom)